These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20526812)

  • 1. CD133+ CD44+ subgroups may be human small intestinal stem cells.
    Hou NY; Yang K; Chen T; Chen XZ; Zhang B; Mo XM; Hu JK
    Mol Biol Rep; 2011 Feb; 38(2):997-1004. PubMed ID: 20526812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The probable role of tumor stem cells for lymph node metastasis in supraglottic carcinoma.
    Lu S; Tian J; Lv Z; Wang H; Bai X; Liu W; Li J; Xu W
    Pathol Oncol Res; 2011 Mar; 17(1):33-8. PubMed ID: 20407935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
    Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
    Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum dots affect expression of CD133 surface antigen in melanoma cells.
    Steponkiene S; Kavaliauskiene S; Purviniene R; Rotomskis R; Juzenas P
    Int J Nanomedicine; 2011; 6():2437-44. PubMed ID: 22072879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.
    Snippert HJ; van Es JH; van den Born M; Begthel H; Stange DE; Barker N; Clevers H
    Gastroenterology; 2009 Jun; 136(7):2187-2194.e1. PubMed ID: 19324043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay.
    Wang F; Scoville D; He XC; Mahe MM; Box A; Perry JM; Smith NR; Lei NY; Davies PS; Fuller MK; Haug JS; McClain M; Gracz AD; Ding S; Stelzner M; Dunn JC; Magness ST; Wong MH; Martin MG; Helmrath M; Li L
    Gastroenterology; 2013 Aug; 145(2):383-95.e1-21. PubMed ID: 23644405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.
    Immervoll H; Hoem D; Steffensen OJ; Miletic H; Molven A
    J Histochem Cytochem; 2011 Apr; 59(4):441-55. PubMed ID: 21411814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
    Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
    Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
    Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
    PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer stem cells--hype or real?: comment on "Combined CD133+/CD44+ expression as a prognostic indicator of disease-free survival in patients with colorectal cancer".
    Ahuja N
    Arch Surg; 2012 Jan; 147(1):24-5. PubMed ID: 22250107
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
    Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
    Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
    Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer.
    Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA
    Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.